Major immunogenic sites of foot-and-mouth disease virus (FMDV) have been mapped to the C-terminal third of capsid protein VP1; we studied the immunogenicity of a series of TrpE-FMDV fusion proteins containing this region of FMDV strain O1 Campos. Fusion protein TrpE-dCN, which contains a dimer of VP1 amino acid sequences consisting of amino acids 200 to 213 linked by a diproline spacer to amino acids 141 to 158 (200-213 ~P-P-G ~ 141-158), induced the best response. A single inoculation of guinea-pigs with 100 ~tg TrpE-dCN elicited high levels of neutralizing antibodies and protected all the animals against challenge infection with homologous virus. Although the closely related FMDV strains O1 Campos and O1 Caseros induced high levels of cross-protection, TrpEdCN-vaccinated guinea-pigs were poorly protected against challenge infection with heterologous FMDV strain O1 Caseros. Nucleotide sequence analysis revealed that amino acid differences at residues 149 and 152 were critical for the induction of crossprotection and that neutralizing epitopes not present in TrpE-dCN are likely to be responsible for conferring a high level of cross-protection between FMDV strains O1 Campos and O1 Caseros.
Major immunogenic sites of foot-and-mouth disease virus (FMDV) have been mapped to the C-terminal third of capsid protein VP1; we studied the immunogenicity of a series of TrpE-FMDV fusion proteins containing this region of FMDV strain O1 Campos. Fusion protein TrpE-dCN, which contains a dimer of VP1 amino acid sequences consisting of amino acids 200 to 213 linked by a diproline spacer to amino acids 141 to 158 (200-213 ~P-P-G ~ 141-158), induced the best response. A single inoculation of guinea-pigs with 100 ~tg TrpE-dCN elicited high levels of neutralizing antibodies and protected all the animals against challenge infection with homologous virus. Although the closely related FMDV strains O1 Campos and O1 Caseros induced high levels of cross-protection, TrpEdCN-vaccinated guinea-pigs were poorly protected against challenge infection with heterologous FMDV strain O1 Caseros. Nucleotide sequence analysis revealed that amino acid differences at residues 149 and 152 were critical for the induction of crossprotection and that neutralizing epitopes not present in TrpE-dCN are likely to be responsible for conferring a high level of cross-protection between FMDV strains O1 Campos and O1 Caseros.
Studies of the structure and antigenic properties of footand-mouth disease virus (FMDV) have provided clues for the development of subunit vaccines with several advantages over the inactivated ones currently in use. It has been shown that VP1, one of the four structural proteins of FMDV, can elicit neutralizing antibodies (Laporte et al., 1973) . Studies with synthetic peptides (Bittle et al., 1982; Pfaff et al., 1982) and cleavage fragments (Strohmaier et al., 1982) of VP1 led to the identification of two regions of VP 1 capable of inducing neutralizing antibodies: an immunodominant site composed of amino acids 140 to 160 and a less immunogenic site composed of amino acids 200 to 213. These two regions, which in the crystal structure of the virus are in close proximity (Acharya et al., 1989) , form a single antigenic domain that contains cross-reactive and specific epitopes (DiMarchi et al., 1986; Parry et al., 1989 a, b) . The immunogenicity of peptides composed of amino acids 140 to 160 and 200 to 213 was studied either separately or by connecting them with a diproline spacer to form the 40 residue peptide Cys-Cys ~ 200-213 --~ Pro-Pro-Ser,-~ 141-158 --~ Pro-CysGly. The latter complex peptide elicited a higher level of neutralizing antibodies than peptide 141-158 alone and protected cattle against challenge infection (DiMarchi et aL, 1986) .
In this paper we characterize the immunogenicity in guinea-pigs of different TrpE-FMDV fusion proteins containing portions of the C terminus of VP1 of FMDV strain O1 Campos (Fig. 1) . Plasmids containing fusion proteins were constructed by cloning cDNA fragments, obtained as described (Piccone et al., 1988) , or synthetic oligonucleotides into the polylinker of expression vector pATH3 (Dieckmann & Tzagalof, 1985) . Constructions were done and verified by nucleotide sequencing as described (Giavedoni, 1988) . TrpE-FMDV fusion proteins, the expression of which is under the control of the tryptophan promoter of Escherichia coli, consist of 322 amino acids of TrpE protein with VP1 sequences fused to their C termini; VP1 sequences encompassed amino acid residues 137 to 213 in TrpE-VP1, 137 to 172 in TrpE-NT, 200 to 213 in TrpE-CT, 200 to 213 linked by a diproline spacer to amino acids 141 to 158 in TrpE-CN, and a dimer of the latter sequence in TrpE-dCN (Fig. 1) .
Fusion proteins were induced in E. coli DH5~ cultures by amino acid starvation and treatment with 3-flindoleacrylic acid; bacteria were broken in a French press and purified as described (Spindler et al., 1984) . Insoluble pellets containing partially purified fusion proteins were solubilized in 7 M-guanidinium hydrochloride, 0.1 ~o 2-mercaptoethanol (2-ME), centrifuged at 40000 g for 16 h and extensively dialysed against UTB 0000-9677 © 1991 SGM Short communication buffer (8 M-urea, 14 mM-Tris-HC1 pH 8.3, 0.I ~ 2-ME). Bacterial extracts were analysed by SDS-PAGE (Fig.  2a) ; proteins of the expected size for TrpE-FMDV fusion proteins were overexpressed and were larger than the 322 residue trpE protein induced in bacteria containing the pATH3 vector ( Fig. 2a ; compare lane 7
with lanes 2 to 6). The amount of induced fusion proteins varied considerably, ranging from more than 70~ of total insoluble proteins in trpE-VP1 (Fig. 2a , lane 6) to less than 5~ in TrpE~clCN (Fig. 2a, lane 2) . Western blot analysis of bacterial extracts stained with rabbit anti-FMDV virion antiserum and goat anti-rabbit peroxidase conjugate (Fig. 2b) showed that all induced fusion proteins except trpE-CT reacted with anti-FMDV antiserum (Fig. 2b ) and confirmed that they contain VPI epitopes. Induced fusion proteins were stable except for TrpE-NT, which was degraded into two smaller species containing VP1 epitopes. Degradation of TrpE-CT is unlikely to be responsible for its lack of reaction with anti-FMDV antiserum (Fig. 2b , lane 5) because a prominent band corresponding to its expected Mr was observed by SDS-PAGE analysis (Fig. 2a , lane 5). Since the region consisting of amino acids 200 to 213 behaves as a poor immunogen (Doel et al., 1988) , it is not surprising that TrpE-CT did not react with anti-FMDV antiserum (Fig. 2b , lane 5). We do not know the nature of the minor band that migrated above TrpE-dCN and reacted with anti-FMDV antiserum (Fig. 2b, lane 2) ; however, it is unlikely that a species of such low abundance represents full-length TrpE-dCN because of its very high M r . The immune response against TrpE-FMDV fusion proteins was assessed in American Short Hair guineapigs vaccinated with fusion proteins in UTB buffer emulsified in Freund's incomplete adjuvant (FIA). Animals were inoculated with 100 ~tg of a given TrpE-FMDV fusion protein (amount estimated by SDS-PAGE) and boosted 28 days post-vaccination (p.v.). II Number of guinea-pigs protected/number challenge-infected with FMDV strain O1 Campos.
Blood samples were taken 28 days and 56 days p.v. and pooled into two groups, except for those from guinea-pigs vaccinated with TrpE and TrpE-CT, which were pooled into one group. Control animals received FIA alone or FIA emulsified with 1 gg acetylethylamine-inactivated virions of strain O 1 Campos. Titres of serum antibody to FMDV were determined by ELISA and neutralization tests in suckling mice (Table 1) . ELISA was done in flexible microtitre plates coated with 0-5 gg pure FMDV strain O1 Campos; sera were titrated on the coated plates and specific antibodies were detected using horseradish peroxidase conjugated to rabbit anti-guinea-pig immunoglobulins. ELISA titres were calculated as the reciprocal of the highest dilution that reacted with FMDV particles. The neutralizing activity of the sera was determined in suckling mice (Skinner, 1953) ; animals were inoculated with 10-fold dilutions of FMDV previously incubated for 1 h at 37 °C with a 1 : 10 dilution of each serum. Neutralizing antibody titres were calculated by the endpoint method (Reed & Muench, 1938) . Vaccination of animals with each of the TrpE-FMDV fusion proteins elicited a rather homogeneous response except in those animals vaccinated with TrpE-CN, which consistently showed a variable response leading to significant differences in antibody titres between the two groups (Table 1) . Virus particles elicited the highest antiserum titres against FMDV, followed by TrpE-dCN, TrpE-NT, and TrpE-VPI and TrpE-CN; a second inoculation of fusion protein increased antibody levels but did not alter the existing relative immunogenic relationship of TrpEdCN > TrpE-NT > TrpE-VP 1 and TrpE-CN (Table 1) . The low response against TrpE-CT was consistent with previous results obtained with synthetic peptides corresponding to the region consisting of amino acids 200 to 213 (Doel et al., 1988) . In order to determine the level of protection against the homologous FMDV strain Ol Campos, TrpE-FMDV-vaccinated guinea-pigs were either challenged 28 days p.v. with 500 guinea-pig infectious doses of FMDV (500 IDs0) by the intraplantar route, or boosted and challenged 28 days later (56 days p.v.). The criterion for protection was the absence of lesions other than at the site of challenge. Table 1 shows that vaccination with TrpE<ICN, which elicited the highest ELISA and neutralization titres, protected 100 ~ of the animals after only one inoculation. Protection levels elicited by the other TrpE-FMDV fusion proteins ranged from 14~o to 40~ after one vaccination and from 38~ to 649/00 after two vaccinations.
To characterize the response against TrpE-dCN further, we challenged TrpE-dCN-vaccinated guineapigs with the closely related FMDV strain O1 Caseros. Animals were vaccinated with 100gg TrpE-dCN, boosted 28 days p.v., and challenged 56 days p.v. with 500 IDso of either FMDV strain O1 Campos or O1 Caseros (Table 2 ). All guinea-pigs were protected against strain O1 Campos whereas only 25 ~o of the animals were protected against strain O1 Caseros; such a poor level of cross-protection correlated with low serum neutralization titres against strain O1 Caseros (Table 2) . This was rather unexpected because vaccination with FMDV strain Ol Campos fully protects guinea-pigs against challenge with strain O1 Caseros (Table 2 ). To study the reasons for such a low level of cross-protection, we sequenced the C terminus of VP 1 of both strains. Three amino acid changes were found within the 141 to 158 immunodominant site: Glu for Asn at position 149, Ala for Lys at position 152, and Val for Ala at position 155 of strains O1 Campos and O1 Caseros, respectively (Fig. 3) . It should be pointed out that the region consisting of amino acids 200 to 213 was identical in each strain. Our results showed that the most immunogenic of the TrpE-FMDV fusion proteins was TrpE-dCN (Table 1) . VP1 sequences in TrpE~tCN are also present in TrpE-VP1 and TrpE-CN, therefore it is likely that the increased immunogenicity of the former resulted from either the presentation of multiple copies of the VP1 epitope (Broekhuijsen et al., 1987; Kleid et al., 1985) or an enhancing effect of linking amino acids 200 to 213 and 141 to 158 by a diproline spacer (DiMarchi et al., 1986) . It has been shown that the contribution of peptide 200-213 to the immunogenicity of the domain is not due to the induction of antibodies directed against its sequence but rather to the highly immunogenic configuration assumed by such a 40 residue peptide (Doel et al., 1988) . Perhaps the intermediate level of protection observed in animals vaccinated with TrpE-NT, TrpE-VP1 and TrpE-CN resulted from unfavourable conformations assumed by these fusion proteins.
Although TrpE-dCN elicited a high level of protection against challenge with the homologous FMDV strain Ol Campos in guinea-pigs, it conferred a low level of cross-protection against the closely related strain O1 Caseros (Table 2 ). This was unexpected because FMDV strains O1 Campos and O1 Caseros display high levels of cross-protection and cross-neutralization (Abaracon & Gomez, 1976) . The change found at position 155 is unlikely to be responsible for the low level of crossprotection because neutralization of type O strains with antisera raised against synthetic peptide Cys-Cys ~ 200-213 ~ Pro-Pro-Gly ~ 141-158 ~ Pro-Cys-Gly is not greatly affected by changes at that position . Conversely, homology within the region consisting of amino acids 145 to 151 appears to be associated with the ability to confer cross-protection (Parry et al., 1989b) ; therefore, it is most likely that changes at amino acid residues 149 and 152 were responsible for the low level of cross-protection (Table 2) . Whether changes at only one position (149 or 152) or at both positions were responsible for the low level of cross-protection is currently under investigation. Doel et al. (1990) suggested that heterotypic protection elicited by synthetic peptides of the general sequence Cys-Cys~200-213 ~ Pro-Pro-Ser ~ 141-158 ~ Pro-Cys-Gly relies largely on amino acids R-G-D (at positions 145 to 147), either in isolation or as part of a larger structure involving conserved amino acids L-A (at positions 151 and 152). It should be pointed out that R-G-D is conserved in almost all the isolates of FMDV sequenced thus far and it has been identified as part of the attachment site on the virus . The two type O FMDV strains studied in this paper (O1 Campos and O1 Caseros) share the R-G-D sequences but differ at position 152, which could account for the lack of cross-protection induced by TrpE-dCN. Consequently, positions 151 and 152 should be taken into consideration for the design of crossprotective FMDV vaccines based on complex peptides.
Four independent neutralizing sites have been mapped in type O FMDV strains using monoclonal antibody neutralization escape mutants (Kitson et al., 1990 and references therein); two of these sites are in VP1, one is in VP2 and the fourth is in VP3. Our results show that FMDV sequences present in TrpE<ICN are not responsible for conferring a high level of crossprotection between strains O1 Campos and Caseros and that other sites are likely to be responsible for doing so. Whether neutralization sites in VP1, VP2 or VP3, or a combination of all of them, are required for eliciting a high level of cross-protection is currently under investigation.
